barbara
03-27-2010, 04:26 PM
March 26, 2010, 6:00 p.m.
Entest BioMedical CEO to Interview Noted Stem Cell Transplant Physician Dr. Ewa Carrier on Advances in Stem Cell Therapy
Interview to Be Conducted on Wednesday March 31; Blogcast at 11:00am PST at
www.entestbioblog.com/live
SAN DIEGO, CA, Mar 26, 2010 (MARKETWIRE via COMTEX) -- Entest BioMedical Inc. /quotes/comstock/11k!entb (ENTB 2.00, +0.05, +2.56%) announced today that Chairman & CEO David Koos will interview noted stem cell transplant physician Dr. Ewa Carrier on the Company's weekly blogcast Wednesday, March 31, 2010 at 11:00 a.m. PST. Dr. Carrier is an internationally recognized expert in stem cell transplantation and a member of Entest's Scientific Advisory Board.
Topics to be covered in the interview will include the role of stem cells in treating cancer, advances in heart and lung treatment with stem cell therapy and the use of stem cells in creating blood for transfusion from stem cells.
Entest's Chairman & CEO David Koos stated, "We are extremely fortunate to have Dr. Carrier on our Scientific Advisory Board. Her knowledge in stem cell therapy applications is of great significance to Entest as the Company moves forward."
The blogcast can be accessed at Company's blog site: www.entestbioblog.com/live Wednesday March 31, 2010 at 11:00 am PST.
Entest BioMedical CEO to Interview Noted Stem Cell Transplant Physician Dr. Ewa Carrier on Advances in Stem Cell Therapy
Interview to Be Conducted on Wednesday March 31; Blogcast at 11:00am PST at
www.entestbioblog.com/live
SAN DIEGO, CA, Mar 26, 2010 (MARKETWIRE via COMTEX) -- Entest BioMedical Inc. /quotes/comstock/11k!entb (ENTB 2.00, +0.05, +2.56%) announced today that Chairman & CEO David Koos will interview noted stem cell transplant physician Dr. Ewa Carrier on the Company's weekly blogcast Wednesday, March 31, 2010 at 11:00 a.m. PST. Dr. Carrier is an internationally recognized expert in stem cell transplantation and a member of Entest's Scientific Advisory Board.
Topics to be covered in the interview will include the role of stem cells in treating cancer, advances in heart and lung treatment with stem cell therapy and the use of stem cells in creating blood for transfusion from stem cells.
Entest's Chairman & CEO David Koos stated, "We are extremely fortunate to have Dr. Carrier on our Scientific Advisory Board. Her knowledge in stem cell therapy applications is of great significance to Entest as the Company moves forward."
The blogcast can be accessed at Company's blog site: www.entestbioblog.com/live Wednesday March 31, 2010 at 11:00 am PST.